High-throughput screening to estimate single or multiple enzymes involved in drug metabolism: microtitre plate assay using a combination of recombinant CYP2D6 and human liver microsomes

By Yamamoto T.   Suzuki A.   Kohno Y.  

Xenobiotica, Vol. 33, Iss. 8, 2003-08 ,pp. : 823-839

Informa Healthcare

Access to resources Recommend Favorite

IC₅₀-based approaches as an alternative method for assessment of time-dependent inhibition of CYP3A4

By Burt Howard J.   Galetin Aleksandra   Houston J. Brian  

Xenobiotica, Vol. 40, Iss. 5, 2010-05 ,pp. : 331-343

Informa Healthcare

Access to resources Recommend Favorite

A General Strategy for the Expression of Recombinant Human Cytochrome P450s in Escherichia coli Using Bacterial Signal Peptides: Expression of CYP3A4, CYP2A6, and CYP2E1

By Pritchard M.P.   Ossetian R.   Li D.N.   Henderson C.J.   Burchell B.   Wolf C.R.   Friedberg T.  

Archives of Biochemistry and Biophysics, Vol. 345, Iss. 2, 1997-09 ,pp. : 342-354

Elsevier

Access to resources Recommend Favorite

Effects of organic solvents on the time-dependent inhibition of CYP3A4 by diazepam

By Nishiya Y.   Nakamura K.   Okudaira N.   Abe K.   Kobayashi N.   Okazaki O.  

Xenobiotica, Vol. 40, Iss. 1, 2010-01 ,pp. : 1-8

Informa Healthcare

Access to resources Recommend Favorite

Cocktail-substrate assay system for mechanism-based inhibition of CYP2C9, CYP2D6, and CYP3A using human liver microsomes at an early stage of drug development

By Mori K.   Hashimoto H.   Takatsu H.   Tsuda-Tsukimoto M.   Kume T.  

Xenobiotica, Vol. 39, Iss. 6, 2009-06 ,pp. : 415-422

Informa Healthcare

Access to resources Recommend Favorite